Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.00
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST
34.57%
Market Cap 1.06B
Revenue (ttm) 1.06B
Net Income (ttm) 96.32M
Shares Out 36.61M
EPS (ttm) 2.61
PE Ratio 11.11
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,000
Average Volume 66,223
Open 28.40
Previous Close 29.00
Day's Range 28.40 - 29.00
52-Week Range 20.30 - 35.85
Beta 0.71
RSI 48.49
Earnings Date May 12, 2026

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince ... [Read more]

Sector Healthcare
Founded 1962
Employees 216
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.